# RienGen completes new GMP production plant in Pyeongtaek, South Korea

RienGen held a completion ceremony for its new GMP production plant in Pyeongtaek, Gyeonggi Province, South Korea. The plant cost 43 billion KRW, has five floors (total floor area 7,972 m²), and increases production capacity tenfold, capable of producing 12 million 1mL syringes, 11 million 5mL vials, and 1.2 million PLA fillers annually.

- Type: New facility
- Announced: 2025-11-06
- Where: Pyeongtaek, Gyeonggi Province, South Korea
- Value: $31.0M (43.0B KRW)
- Starts operating: 6 Nov 2025
- Status: completed
- Capacity: 12 million 1mL syringes, 11 million 5mL vials, 1.2 million PLA fillers per year
- Products: syringes, vials, PLA fillers, RN-P2501 new material
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [RienGen](https://endata.com/companies/88616.md)

## Sources

- [snakorea.com](http://www.snakorea.com/news/articleView.html?idxno=976811), 2025-11-21: "평택 신공장은 리엔젠의 기술력과 예술적 감성이 융합된 'Life Engineering' 철학을 구현한 결실"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
